Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Ferrari

Showing results (121-130 of 234) with videos related to

Pageof 24
Sort By:
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 5, 2008
Increased immunostimulatory activity conferred to antigen-presenting cells by exposure to antigen extract from hepatocellular carcinoma after radiofrequency thermal ablationAlessandro Zerbini, Massimo Pilli, Francesco Fagnoni, et al.
Plos Pathogens|September 3, 2010
Contribution of herpesvirus specific CD8 T cells to anti-viral T cell response in humansElena Sandalova, Diletta Laccabue, Carolina Boni, et al.
International Journal of Molecular Sciences|October 17, 2019
The Good and the Bad of Natural Killer Cells in Virus Control: Perspective for Anti-HBV TherapyPaola Fisicaro, Marzia Rossi, Andrea Vecchi, et al.
Gastroenterology|October 6, 2009
Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis BPaola Fisicaro, Caterina Valdatta, Marco Massari, et al.
Hepatology (Baltimore, Md.)|February 24, 2006
The influence of T cell cross-reactivity on HCV-peptide specific human T cell responsePatrick T F Kennedy, Simonetta Urbani, Rebecca A Moses, et al.
Nucleic Acids Research|October 30, 2024
RepeatsDB in 2025: expanding annotations of structured tandem repeats proteins on AlphaFoldDBDamiano Clementel, Paula Nazarena Arrías, Soroush Mozaffari, et al.
Annals of Surgery|April 20, 2018
Enhanced Recovery After Surgery (ERAS) Pathway in Esophagectomy: Is a Reasonable Prediction of Hospital Stay Possible?Paolo Parise, Carlo Ferrari, Andrea Cossu, et al.
Gastroenterology|August 30, 2012
Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCVPaola Fisicaro, Caterina Valdatta, Marco Massari, et al.
Frontiers in Immunology|June 2, 2020
Pathogenetic Mechanisms of T Cell Dysfunction in Chronic HBV Infection and Related Therapeutic ApproachesPaola Fisicaro, Valeria Barili, Marzia Rossi, et al.
Chirurgia Italiana|January 13, 2006
[Liver trauma: experience in the management of 252 cases]Fabio Colombo, Fabio Sansonna, Fabio Baticci, et al.
Pageof 24

Showing results (121-130 of 234) with videos related to

Sort By:
Pageof 24
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 5, 2008
Increased immunostimulatory activity conferred to antigen-presenting cells by exposure to antigen extract from hepatocellular carcinoma after radiofrequency thermal ablationAlessandro Zerbini, Massimo Pilli, Francesco Fagnoni, et al.
Plos Pathogens|September 3, 2010
Contribution of herpesvirus specific CD8 T cells to anti-viral T cell response in humansElena Sandalova, Diletta Laccabue, Carolina Boni, et al.
International Journal of Molecular Sciences|October 17, 2019
The Good and the Bad of Natural Killer Cells in Virus Control: Perspective for Anti-HBV TherapyPaola Fisicaro, Marzia Rossi, Andrea Vecchi, et al.
Gastroenterology|October 6, 2009
Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis BPaola Fisicaro, Caterina Valdatta, Marco Massari, et al.
Hepatology (Baltimore, Md.)|February 24, 2006
The influence of T cell cross-reactivity on HCV-peptide specific human T cell responsePatrick T F Kennedy, Simonetta Urbani, Rebecca A Moses, et al.
Nucleic Acids Research|October 30, 2024
RepeatsDB in 2025: expanding annotations of structured tandem repeats proteins on AlphaFoldDBDamiano Clementel, Paula Nazarena Arrías, Soroush Mozaffari, et al.
Annals of Surgery|April 20, 2018
Enhanced Recovery After Surgery (ERAS) Pathway in Esophagectomy: Is a Reasonable Prediction of Hospital Stay Possible?Paolo Parise, Carlo Ferrari, Andrea Cossu, et al.
Gastroenterology|August 30, 2012
Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCVPaola Fisicaro, Caterina Valdatta, Marco Massari, et al.
Frontiers in Immunology|June 2, 2020
Pathogenetic Mechanisms of T Cell Dysfunction in Chronic HBV Infection and Related Therapeutic ApproachesPaola Fisicaro, Valeria Barili, Marzia Rossi, et al.
Chirurgia Italiana|January 13, 2006
[Liver trauma: experience in the management of 252 cases]Fabio Colombo, Fabio Sansonna, Fabio Baticci, et al.
Pageof 24